<?xml version='1.0' encoding='UTF-8'?><rdsi.pacelf.phase3:document xmlns:rdsi.pacelf.phase3='http://www.example.com' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' ><PacELF_ID>1195</PacELF_ID><type>Hardcopy</type><category>Correspondence and Emails</category><hardcopy_location>JCU WHOCC Ichimori collection</hardcopy_location><title>Subject: Concerns</title><description>Email about Cochrane review of albendazole for LF</description><year>2010</year><authors>Daumerie, D.P.J.</authors><pages>2</pages><work_location>Multicountry Global</work_location><language>English</language><access_rights>Restricted</access_rights><decade>2010</decade></rdsi.pacelf.phase3:document>